IFNG and neoplasm: In summary, tumor cells can mount IFN-γ resistance at two stages: disruption of the main signal transduction pathway responsible for all downstream effects of IFN-γ stimulation, and the alternative expression/suppression of specific key ISG or a group of ISGs with synergistic functions.